1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Pharmaceutical Industry in Australia Market Research & Statistics

Pharmaceutical Industry in Australia Market Research & Statistics

24/7 Customer Support

Talk to Sam

+1 718 473 0872

All regions

About 1 600 reports

Download Unlimited Documents from Trusted Public Sources

The future of the Pharmaceutical Industry in Australia

  • January 2016
    28 pages
  • Pharmaceutical  

  • Australia  

    World  

View report >

Pharmaceutical Industry in Australia

  • January 2016
    22 pages
  • Pharmaceutical  

  • Australia  

    Oceania  

View report >

Pharmaceutical Industry

  • August 2015
    104 pages
  • Pharmaceutical  

  • Canada  

    Australia  

    United Kingdom  

View report >

Pharmaceutical Industry in Australia

  • August 2015
    23 pages
  • Pharmaceutical  

    Pharmaceutical  

  • Australia  

View report >

Pharmaceutical Industry in Australia - Forecast

  • July 2015
    14 pages
  • Pharmaceutical  

  • Australia  

View report >

Pharmaceutical Industry in Australia - Forecast

  • July 2015
    5 pages
  • R-and-D  

    Pharmaceutical  

  • Australia  

    Oceania  

View report >

Pharmaceutical Industry in Australia

  • July 2015
    5 pages
  • Pharmaceutical  

  • Australia  

    Oceania  

View report >

Pharmaceutical Industry in Australia - Forecast

  • May 2015
    23 pages
  • Pharmaceutical  

  • Australia  

View report >

Pharmaceutical Industry

  • May 2015
    12 pages
  • Pharmaceutical  

  • United Kingdom  

    United States  

    Australia  

View report >

Pharmaceutical Industry

  • May 2015
    12 pages
  • Pharmaceutical  

  • United Kingdom  

    United States  

    Australia  

View report >


About 200 reports

Purchase Reports From Reputable Market Research Publishers
(From $ 99 - $ 4 995)

Non-Small Cell Lung Cancer Therapeutics in Asia-Pacific Markets to 2022 - Launch of Premium Targeted Therapies and Increasing Prevalence to Drive the Market

Non-Small Cell Lung Cancer Therapeutics in Asia-Pacific Markets to 2022 - Launch of Premium Targeted Therapies and Increasing Prevalence to Drive the Market

  • $ 4 995
  • Industry report
  • May 2016
  • by GBI Research

Non-Small Cell Lung Cancer Therapeutics in Asia-Pacific Markets to 2022 - Launch of Premium Targeted Therapies and Increasing Prevalence to Drive the Market Summary Non-Small Cell Lung Cancer (NSCLC) is ...

2016-2020 Australia Clinical Chemistry And Immunodiagno ...

May 2016 $ 2 450

Ims Pharmaceutical Pricing & Reimbursement Concise Guid ...

June 2016 $ 1 700

Australia Pharmaceuticals And Healthcare Report Q3 2016

May 2016 $ 1 300

Factor Therapeutics Ltd. (australia)

May 2016 $ 950

Tfs Corporation Limited – Mergers & Acquisitions (m&a ...

June 2016 $ 350

Mesoblast Limited – Mergers & Acquisitions (m&a), Par ...

June 2016 $ 350

Phosphagenics Limited – Mergers & Acquisitions (m&a), ...

June 2016 $ 350

Circadian Technologies Limited – Mergers & Acquisitio ...

June 2016 $ 350

Aspen Pharmacare Holdings Limited – Mergers & Acquisi ...

June 2016 $ 350

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.